Postmarathon paradox: insulin resistance in the face of glycogen depletion. Am. J. Physiol. 270 (Endocrinol. Met&.
33): E336-E343, 1996.-Acute physical exercise enhances insulin sensitivity in healthy subjects. We examined the effect of a 42-km marathon run on insulin sensitivity and lipid oxidation in 19 male runners. In the morning after the marathon run, basal serum free fatty acid concentration was 2.2-fold higher, muscle glycogen content 37% lower (P < O.Ol), glycogen synthase fractional activity 56% greater (P -=c O.Ol), and glucose oxidation reduced by 43% (P < O.Ol), whereas lipid oxidation was increased by 55% (P -=c 0.02) compared with the control study. During euglycemic-hyperinsulinemic clamp, whole body glucose disposal was decreased by 12% (P < 0.01) because of a 36% lower glucose oxidation rate (P < O.OS), whereas the rate of lipid oxidation was lo-fold greater (P < 0.02) than in the control study. After the marathon, muscle glycogen content correlated positively with lipid oxidation (r = 0.60, P < 0.05) and maximal aerobic power ~~~~~~~~~ r = 0.61, P < 0.05). Vo2peak correlated positively with basal lipid oxidation (r = 0.57, P < 0.05). In conclusion, 1) after the marathon run, probably because of increased lipid oxidation, the insulin-stimulated glucose disposal is decreased despite muscle glycogen depletion and the activation of glycogen synthase; 2) the contribution of lipid oxidation in energy expenditure is increased in proportion to physical fitness; 3) these adaptations of fuel homeostasis may contribute to the maintenance of physical performance after prolonged exercise.
exercise; glucose uptake; insulin sensitivity; lipid metabolism; glycogen; glycogen synthase A MARATHON RUN is one of the most extreme conditions for humans to stress physiological homeostasis. In particular, there are great demands for the adaptation of fuel homeostasis. If a marathon run is performed at an intensity close to 65% of maximal aerobic power . m Zpeak), the total energy consumption is in the range of 2,400-2,800 kcal (lO,OOO-12,000 kJ), which is equal to or more than the energy consumption during the whole day in most people (28) . Anumber of studies have addressed how the body will adjust to this stress during exercise (1, 3, 13, 28) . When exercise is performed after an overnight fast, muscle glycogen and blood-borne glucose are the major sources of fuel during the 1st h (1). After that, there is a shift to greater fat utilization, and the contribution of free fatty acids (FFA) increases progressively when the exercise is prolonged (1). However, if carbohydrate is given during exercise, the respiratory quotient remains above 0.90, indicating a high continuous use of carbohydrate as a fuel (26). The recovery of fuel homeostasis after a marathon run is less well known. If exercise is performed in the fasting state, the enhanced fat oxidation is still going on after exercise, leading to a decrease in glucose utilization (20) . The duration of increased fat oxidation is not known. Neither is it known whether enhanced fat utilization occurs if carbohydrate is ingested during exercise as is done during the marathon run. Because a fast repletion of muscle glycogen stores is crucial for the recovery of performance, it is important to know the duration of enhanced postexercise fat utilization and its effect on the repletion of glycogen stores. In untrained individuals, glucose disposal was decreased 48 h after they had performed eccentric exercise (downhill running), whereas no effect on glucose uptake was seen after concentric exercise (18). Because eccentric exercise causes muscle soreness and high elevations in serum creatine kinase concentrations, a decrease in glucose uptake after eccentric exercise was considered to be a consequence of muscle damage rather than a metabolic adaptation (18, 22) .
Long-term exercise leads to glycogen depletion, which is an important stimulator of glycogen synthesis regardless of ambient insulin concentrations (8, 13). On the other hand, we have recently demonstrated an inverse relationship between serum FFA concentration and muscle glycogen content as determined by the euglycemic insulin clamp (9). These data suggest that after the marathon run there are two factors with partly opposing effects on glycogen synthesis: low glycogen content stimulates the glycogen synthase activity, whereas high FFA levels seem to regulate the amount of glycogen in muscle when the glycogen stores are filling. The net outcome of these opposite effects is not known. Consequently, the present study was planned to examine, in healthy humans, the rates of glucose and fat utilization, muscle glycogen synthesis, and their interrelationships the day after a competitive marathon run.
METHODS

Subjects
Nineteen male runners with the mean age of 39 t 2 yr, body mass index (BMI) of 22.8 t 0.3 kg/m", and maximal
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. (voaprak) of 47 t 2 ml l kg-l* mini (range 37.4-55.9 ml*kg-l*min-l) participated in the study. All subjects were healthy, and none of them was using any medication.
The subjects had been training for the marathon by running 40-60 km/wk for ~4 mo. For 2 days before the control study, the subjects did not participate in any training and had a diet containing 250-300 g carbohydrate per day. The purpose, nature, and possible risks of the study were explained to all subjects before informed consent was obtained. The study protocol was approved by the Ethical Committee of the Helsinki University Hospital.
Design
The study consisted of three parts. First, blood samples were taken before, during, and after the 42-km marathon run. Second, euglycemic insulin clamp with muscle biopsies and indirect calorimetry was done on the day after the marathon run. Third, a control insulin clamp study was performed after a resting day 2-3 wk after the marathon run. In addition, VO 2peak was determined in each subject to characterize physical fitness and, in a part of the group, muscle histological examination and magnetic resonance imaging (MRI) from thighs were performed to reveal any muscle damage.
Marathon Study
Each subject ran a competitive 42-km marathon race starting at 3:30 P.M. One hour before, in the middle of the race (20 km), and immediately after the race, a blood sample (45ml each) was taken from the antecubital vein. The mean duration of the race was 3 h and 34 min (range from 2 h and 40 min to 4 h and 45 min). The food intake before, during, and after the race was according to individual habits, without any influence by the investigators.
On the basis of the interview, mean carbohydrate intake in the preceding day was 510 -+ 70 g, and during the marathon day it was 237 5 68 g, from which 48% was ingested before, 10% during, and 42% after the race. The estimated energy intake during the marathon day was 3,230 2 230 kcal.
Insulin Clamp
After an overnight lo-to 12-h fast, both after the day of marathon run and after a resting control day, we performed a 240-min euglycemic insulin clamp study in 14 subjects, as previously described (6,s). One catheter was inserted into an antecubital vein for the infusion of insulin and glucose, and another was inserted into a heated hand vein (kept in a box at 60°C) for the sampling of arterialized blood and other specimens. Insulin (Actrapid Human, Novo Nordisk, Copenhagen, Denmark) was infused in a primed-continuous rate [9 nmol (1.5 mU)*kg-l*min-l] for 240 min. Plasma glucose was maintained at the fasting level, with 20% glucose infused at a variable rate based on plasma glucose determinations from the arterialized blood measured at 5-to IO-min intervals. Because hepatic glucose production is totally suppressed with even lower insulin infusion rates than those employed here, the glucose infusion rate corrected for changes in plasma glucose concentration equals the rate of glucose disposal. In the subjects not participating in the clamp studies (n = 5), only fasting blood samples were taken. 
Muscle Biopsies
A percutaneous biopsy was performed in all 19 subjects on the morning after the marathon run and after a resting control day. In the subjects participating in the clamp study (n = 14), the biopsy was performed in the opposite legs before and at the end of the insulin clamp study, similarly in both studies. In the subjects not participating in the clamp studies (n = S), only one biopsy was performed after an overnight fast in the morning after the marathon run and after the resting control day. The specimen (100-150 mg) was taken from m. vastus lateralis with a Bergstrom needle under local anesthesia (1% lidocaine).
The samples were removed from muscle with suction by a syringe attached to the needle. For biochemical studies, a sample was immediately placed in liquid N2, where it was stored until analyzed. For histological studies, a sample was immediately placed into 2.5% phosphate-buffered glutaraldehyde solution (pH 7.2) for several hours, changed to 0.05 M phosphate buffer, and stored at 4°C until further processed.
Muscle Assays
Muscle glycogen and glycogen synthase assays were done as previously described (8). The muscle samples were freezedried and dissected free from blood and connective tissue. Approximately 10 mg of muscle were powdered, weighed, and used for glycogen determination.
Muscle powder was extracted with KOH and neutralized, glycogen was hydrolyzed with amyloglycosidase, and the liberated glucose was analyzed with the glucose oxidase method. Glycogen concentration is expressed as millimoles per kilogram of dry muscle. Glycogen synthase activity was measured by a fluorometric method, as described previously (8). This method determines the production of uridine diphosphate (UDP) from the incorporation of UDP-glucose in glycogen. Samples and blanks were incubated for 15 min at 37°C with 0.1 and 10 mmol/l glucose 6-phosphate (G-6-P). The enzyme activity determined at 0.1 mmol/l G-6-P is called glycogen synthase activity, and the ratio of the activities at 0.1 and 10 mmol/l G-6-P is called glycogen synthase fractional activity. The assay was linear for protein concentration in the homogenate. Protein concentration was determined according to Lowry et al. (23) . After the marathon run, both glycogen and glycogen synthase activity were determined in 16 subjects in the basal state and in 12 subjects after the insulin clamp. In the control study the number of basal and postclamp determinations was 15 and 11, respectively. as standard. After both the marathon and the control days, GLUT-4 protein was determined from 17 subjects in the basal state and from 12 subjects (11 at control study) after the insulin clamp. Because of the small sample size, muscle glycogen synthase mRNA was quantified after the marathon day in 8 subjects (6 studied with the clamp) and after the control day in 7 subjects (5 with the clamp).
Immunoblotting
Muscle was homogenized (Polytron, Brinkman, Westbury, NY) on ice at high speed for 45 s in HES buffer (20 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid, 1 mM EDTA, 250 mM sucrose, pH 7.4; 1:40, wt/vol). The protein concentration was determined by a method based on the reaction with bicinchoninic acid (Pierce Europe), and 50-ug samples were subjected to SDS-polyacrylamide gel electrophoresis. Protein was electrophoretically transferred to nitrocellulose paper (MilliBlot-SDE System, Millipore, American Bionetics).
Nitrocellulose sheets were incubated with phosphate-buffered saline (pH 7.4) containing 50 mg/ml of powdered milk (Valio, Helsinki, Finland) for 60 min at 22°C and thereafter with a polyclonal antibody specific for the GLUT-4 carboxy-terminal (F349 Results are given as means t SE.
RESULTS
Blood Determinations During and After the Marathon
Plasma glucose concentration remained unchanged, whereas serum insulin concentration decreased and the counterregulatory hormones (cortisol, glucagon, growth hormone) all increased significantly (Table 1 ). In addition, there was a 7.3-fold elevation in serum FFA concentration. In the morning after the marathon run, serum FFA concentration was still 2.2-fold higher than on the control morning. During the insulin infusion studies, serum FFA levels decreased similarly in both studies (P < 0.001) but were still higher at the postexercise study (the average between 30 and 240 min, 122 t: 6 vs. 108 t 6 umol/l, P < 0.01, respectively). Serum CK concentration rose 3-fold during the race, and the increase continued, leading to a 13-fold elevation the next morning compared with the prerace concentration. A similar pattern was seen in the rise of serum AST concentration, with a 2.5fold elevation in the morning after the marathon run (Table 1 ). The changes of CK and AST during the run correlated also with . vo 2 peak (r = 0 51 P < 0.05 and r = 0.70, P < 0.001, . respectively). There was a small but significant in-control day, basal oxidative glucose disposal correlated crease in blood hemoglobin and serum creatine concen-inversely with serum FFA concentration (Fig. 2) , and trations, thus reflecting a slight dehydration during the when the two studies were combined (r = -0.61, P < run (Table 1) . O.Ol), but not on the day after the marathon (r = 0.02, Glucose Disposal not significant).
Fasting plasma glucose and serum insulin concentraLipid Oxidation tions were similar in the morning after the marathon After the marathon, lipid oxidation was 55% higher run and on the control day (Table 1) . During hyperinsuin the basal state and lo-fold higher during the last 30 linemia (30-240 min of insulin infusion), steady-state min of insulin infusion compared with the control day plasma glucose (5.2 ? 0.1 vs. 5.1 t 0.1 mmol/l) and (Fig. 3) . There was a close inverse relationship between insulin concentrations (670 t 19 vs. 682 t 29 pmol/l) lipid and glucose oxidation both in the basal state (r = were similar during the postmarathon and the control -0.90, P < 0.001) and during insulin infusion (r = clamp studies, respectively. In the basal state, the rate -0.97, P < 0.001) after the marathon and on the of glucose oxidation was 43% lower after the marathon control day (r = -0.67 and -0.70, P < 0.05, in both, than on the control day (4.8 t 1.1 vs. 8.3 t 1.1 respectively). In the control study, basal FFA levels umol l kg-l. mini, P < 0.05, respectively). During insu-correlated positively with basal lipid oxidation (r = lin infusion (30-240 min), the whole body glucose 0.52, P < 0.05). After the marathon, basal lipid oxidadisposal was 12% lower after the marathon than on the control day (57.7 t 2.1 vs. 65.4 t 2.6 umol*kgP1~minl, P < 0.01, Fig. 1 ). This difference is accounted for by the 36% lower glucose oxidation rate (17.2 t 1.3 vs. 23.3 t 1.1 umol l kg-l l minl, P < 0.02), because nonoxidative glucose disposal rates were similar in both studies (40.5 t 2.4 vs. 42.2 t 2.9 umol*kgP1~minl, Fig. 1 ). When the two studies were combined, the basal serum FFA levels correlated inversely with the whole body glucose disposal rate (r = -0.40, P < 0.05). On the Post-marathon tion correlated inversely with total glucose disposal (r = -0.58, P < O.OS), and v02peak correlated positively with lipid oxidation both in the basal state and during hyperinsulinemia (r = 0.57 and 0.55, P < 0.05 in both, respectively). Of enhanced lipid oxidation after the marathon, 44% was explained by Vozpeak and duration of the race together (P < O.OS>, whereas 23% was explained by Vozpeak alone (P < 0.05) in a multipleregression analysis. 
Energy Expenditure
On the morning after the marathon, basal energy expenditure was 6% higher than on the control morning (5.5 t 0.1 vs. 5.2 t 0.1 kJ/min, respectively, P < 0.002, Fig. 4 ). The increase was entirely due to a higher lipid oxidation after the marathon, whereas protein oxidation was equal in both studies. During insulin infusion, energy expenditure increased similarly after the marathon (to 6.1 t 0.1 kJ/min, P < 0.001) and on the control day (to 5.9 t 0.1 kJ/min, P < 0.001). vo2peak and energy expenditure during hyperinsulinemia were positively related after the marathon (r = 0.52, P < 0.05). Energy expenditure during hyperinsulinemia was not related to simultaneous serum FFA concentration.
Muscle Determinations
Glycogen. On the morning after the marathon, basal muscle glycogen content was 37% lower than on the control day (Fig. 5) . Muscle glycogen during the clamp studies increased significantly by 20% (P = 0.02) when the two studies were pooled together, but the changes were not significant when analyzed separately. The postclamp muscle glycogen content was 32% lower after the marathon than after the respective concentration on the control day (P < 0.01). On the postmarathon
Control
Post-marathon and control days, the basal muscle glycogen content correlated inversely with respective fasting serum FFA (r = -0 68 P < 0.01 and r = -0.64, P -=c 0.05). The basal muscle glycogen content after the marathon correlated inversely with serum insulin (r = -0.60, P < 0.05) concentrations and positively with basal lipid oxidation (r = 0.60, P < 0.05), whereas the rise in muscle glycogen content after the marathon correlated positively with total glucose disposal rate (r = 0.74, P < 0.01) and inversely with the basal rate of lipid oxidation (r = -0.62, P < 0.05). ire 2peak correlated on the morning after the marathon with the basal glycogen content (r = 0.61, P < 0.05). Glycogen synthase. The day after the marathon, basal muscle glycogen synthase activity was 73% higher (P < 0.05) and the fractional activity was 56% higher (P < 0.01) than on the control day (Table 2) . During insulin infusion, glycogen synthase fractional activity increased in both studies, whereas the synthase activity rose only after the marathon day. However, the fractional activity after insulin infusion was still higher after the marathon than on the control day (Table 2) . After the marathon, basal muscle glycogen synthase fractional activity correlated positively with total glucose disposal (r = 0.63, P < 0.05) and the rise in muscle glycogen content (r = 0.62, P -=c 0.05) but inversely with basal glycogen content (r = -0.59, P < 0.05)? basal lipid oxidation rate (r = -0.72, P < O.Ol), and V02pcnk (r = -0.87, P < 0.01). After the marathon there was a negative correlation between muscle glycogen synthase fractional activity and energy expenditure both in the basal state (r = -0.76, P < 0.01) and at the end of the clamp (r = -0.65, P < 0.05).
Glycogen synthase mRNA. After the marathon, the basal muscle glycogen synthase mRNA content was 30% lower than the control value, as expressed per total RNA (Table 2) . During insulin infusion, glycogen synthase mRNA increased after the marathon, when expressed either per total RNA (increase 82%) or per total DNA (130%), whereas no change occurred in the control study (Table 2) .
Glucose transport protein (GLUT-4) and its mRNA. Basal muscle glucose transport protein concentration was virtually indistinguishable after the marathon and in the control study (675 _ + 53 vs. 678 t 74 densitomet- G-6-P, glucose 6-phosphate. Significant differences from respective sample on control day: *P < 0.05; from basal sample on same day: TP < 0.05; $P < 0.01. ric U/mg protein, respectively).
In both studies, the values remained unchanged after insulin infusion (699 2 58 vs. 625 t 57 densitometric U/mg protein, respectively).
GLUT-4 mRNA content, regardless of whether it was expressed per total RNA or total DNA, was similar in the morning after the marathon and after the resting day (data not shown) and remained unchanged during insulin clamp studies on both days.
MRI and muscle histology. No abnormal signal changes indicating muscle damage were detected in the postmarathon Tz-weighted images, and there was no difference between the postmarathon and control day MRIs. There were no indications of muscle damage in the histological structure of the muscle samples studied. DISCUSSION A number of studies have demonstrated that major regulators of muscle glycogen synthesis in healthy humans are ambient glycogen concentration and glycogen synthase activity (5, 8, 9, 13, 14) . These studies, however, have been performed in subjects not exposed to exercise, or the exercise has been of short duration (14). In the current study after the marathon run, muscle glycogen content was decreased and the synthase activity increased. In addition, basal muscle glycogen synthase fractional activity correlated inversely with basal glycogen content and positively with the rise in glycogen, and the rise in glycogen was also related to total glucose disposal rate. During hyperinsulinemia, glycogen synthase activity, enzyme fractional activity, and mRNA content all increased significantly. However, these changes or the associations with glucose metabolism did not lead to a significantly greater rise in muscle glycogen content or the whole body glucose disposal after the marathon compared with the control study. Neither did we see any changes in muscle GLUT-4 protein content, although its mRNA level increased significantly by hyperinsulinemia after the marathon.
These data suggest that, after the marathon, other mechanisms overcame the regulatory role of low muscle glycogen content and increased glycogen synthase activity to stimulate oxidative glucose disposal and glucose storage as glycogen beyond a level seen in the control study. During the marathon, there was a significant rise in serum glucagon, cortisol, and growth hormone concentrations.
However, none of these hormones was elevated on the morning after the race. Thus, provided there is any long-term effect, counterregulatory hormones probably had no major contribution to the decrease in insulin-mediated glucose disposal observed the day after the marathon run. The range of individual duration of the race varied greatly. Because of the competitive status of the race, the relative intensity can be considered about the same in each individual.
Thus the differences in relative exercise intensity probably do not contribute to the results of this study.
Regarding muscle damage, the race was run on streets with a hard surface, and the runners had elevated levels of CK and AST. These elevations were proportional to VO, peak, suggesting that those running with the highest intensity also had the greatest muscle damage. In previous studies, it has been suggested that muscle damage can contribute to decreased insulinmediated glucose disposal immediately after exercise (l&22).
However, we were unable to detect any muscle damage in the histological or MRI examination of the muscle. Because these methods are sensitive in revealing muscle damage (21), we can exclude alterations in muscle structure as a major contributing factor to reduced muscle glucose uptake the day after the marathon.
The diet before, during, and after exercise was based on individual habits of the runners. The total carbohydrate uptake on the marathon day did not differ from a normal day, probably leading to a negative energy balance on the day of exercise. After the race, the subjects ingested -40% of the carbohydrates of that day with the last intake at 10 P.M., so the fasting period before the insulin clamp study did not differ from the control situation.
The total energy intake during the marathon day was slightly more than the energy spent during the race (28). Thus, although the energy balance for the whole day may have been slightly negative, the
